News

SMALL-CAP WINNERS & LOSERS: Regional REIT celebrates new transactions
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.
Vor Biopharma: Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis ...
The Pharma Letter5h
Vor Bio licenses telitacicept from RemeGen
PureTech Heath founded clinical-stage biotech Vor Bio has entered into an exclusive license agreement with RemeGen to develop ...
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global ...